Vontobel Holding
BMY icon

Vontobel Holding’s Bristol-Myers Squibb BMY Stock Holding History

Vontobel Holding’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$47.9M Buy
767,237
+41,650
+6% +$2.63M 0.17% 129
2026
Q2 		$41.8M Buy
725,587
+29,767
+4% +$1.71M 0.13% 154
2026
Q1 		$42.2M Sell
695,820
-67,308
-9% -$3.92M 0.15% 136
2025
Q4 		$41.2M Sell
763,128
-248,546
-25% -$12M 0.13% 137
2025
Q3 		$45.6M Sell
1,011,674
-46,675
-4% -$2.18M 0.14% 111
2025
Q2 		$49M Sell
1,058,349
-221,606
-17% -$10.9M 0.16% 102
2025
Q1 		$78.1M Buy
1,279,955
+286,145
+29% +$16.7M 0.28% 62
2024
Q4 		$56.2M Sell
993,810
-31,864
-3% -$1.78M 0.19% 78
2024
Q3 		$53.1M Buy
1,025,674
+42,456
+4% +$1.99M 0.17% 101
2024
Q2 		$40.8M Sell
983,218
-65,906
-6% -$2.95M 0.13% 108
2024
Q1 		$56.9M Buy
1,049,124
+2,144
+0.2% +$109K 0.45% 53
2023
Q4 		$53.7M Sell
1,046,980
-888,942
-46% -$46.7M 0.45% 52
2023
Q3 		$112M Buy
1,935,922
+266,112
+16% +$16.3M 1.04% 16
2023
Q2 		$107M Sell
1,669,810
-200,192
-11% -$13.4M 0.94% 18
2023
Q1 		$130M Buy
1,870,002
+31,802
+2% +$2.24M 1.21% 11
2022
Q4 		$132M Buy
1,838,200
+198,230
+12% +$14.9M 1.34% 8
2022
Q3 		$117M Buy
1,639,970
+102,316
+7% +$7.42M 1.36% 8
2022
Q2 		$120M Sell
1,537,654
-239,989
-14% -$18.3M 1.3% 11
2022
Q1 		$131M Buy
1,777,643
+805,626
+83% +$54.1M 1.13% 16
2021
Q4 		$60.8M Sell
972,017
-35,735
-4% -$2.1M 0.51% 41
2021
Q3 		$59.6M Sell
1,007,752
-485,964
-33% -$32M 0.53% 39
2021
Q2 		$99M Buy
1,493,716
+480,293
+47% +$31.3M 0.86% 22
2021
Q1 		$64M Buy
1,013,423
+98,389
+11% +$6.12M 0.47% 27
2020
Q4 		$55.1M Buy
+915,034
New +$56.3M 0.36% 40

Other funds holding BMY

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Independent Franchise Partners
Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Vontobel Holding's BMY Position: Q3 2026 in Review

Vontobel Holding increased its Bristol-Myers Squibb (BMY) stake by 5.7% in Q3 2026, buying an estimated $2.63M and bringing the position to 767,237 shares worth $47.9M. The position accounts for 0.17% of the portfolio, ranked #129.

Vontobel Holding first reported a position in BMY in Q4 2020 and has held it in 24 quarters since. The position peaked at $132M in Q4 2022. 2,059 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Vontobel Holding held 767,237 shares of Bristol-Myers Squibb worth $47.9M as of Q3 2026.
  • Vontobel Holding bought 41,650 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.63M.
  • Bristol-Myers Squibb made up 0.17% of Vontobel Holding's portfolio in Q3 2026, its #129 holding.
  • Vontobel Holding first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 24 quarters since.
  • Vontobel Holding's Bristol-Myers Squibb position peaked at $132M in Q4 2022.
  • 2,059 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.